Global /China /Healthcare /Drug Manufacturers - Specialty & Generic /002412

Hunan Hansen Pharmaceutical Co., Ltd.

002412

• SHE: 002412 • Delayed

6.99CNY -0.3%

1.03 USD

As of 7 June 2026, Hunan Hansen Pharmaceutical Co., Ltd. has a market cap of $521.08M USD, ranking #14841 globally and #4621 in China. It ranks #1322 in the Healthcare sector, and #75 in the Drug Manufacturers - Specialty & Generic industry.

Global Rank

14841

Country Rank

4621

Sector Rank

1322

Industry Rank

Key Stats

Market Cap

$521.08MUSD

3.53B CNY

Enterprise Value

$443.97MUSD

3.01B CNY

Revenue (TTM)

$155.3MUSD

1.05B CNY

EBITDA (TTM)

$43.23MUSD

292.86M CNY

Net Income (TTM)

$25.41MUSD

172.02M CNY

EBITDA Margin

28%

Profit Margin

16%

PE Ratio

20.5

PS Ratio

3.4

PB Ratio

1.6

EV/EBITDA

10.3

Company Profile

Country (HQ)

China

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Zhengqing Liu open_in_new

Employees

1,675

Founded

1998

Website

hansenzy.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-0.3%	7.8%	7%	3.2%	11%	9.4%	26%	5.6%	18%

News

Markets

Exchange	Ticker	Price	Quotes
Shenzhen Stock Exchange (SHE / SZSE) MIC: XSHE PRIMARY	002412 湖南汉森制药股份有限公司 Class A ISIN: CNE100000PK2 Shares Out.: Shares Outstanding: 503.2M¹ Shares Float: 295.487M² TV: TradingView: SZSE: 002412 SA: Stock Analysis: SHE: 002412 YF: Yahoo Finance: 002412.SZ GF: Google Finance: SHE: 002412 BA: Barron's: 002412 MS: Morningstar: XSHE: 002412	6.99 CNY	TV: TradingView: SZSE: 002412 SA: Stock Analysis: SHE: 002412 YF: Yahoo Finance: 002412.SZ GF: Google Finance: SHE: 002412 BA: Barron's: 002412 MS: Morningstar: XSHE: 002412

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Hunan Hansen Pharmaceutical Co., Ltd.

Hunan Hansen Pharmaceutical Co., Ltd. engages in the production and sale of traditional Chinese preparations in China and internationally. The company offers digestive system medicines; cardiovascular and cerebrovascular medicines; kidney-tonifying and urine-reducing medicines; trauma medicines; diagnostic medicines, etc. It provides medicines in injection, mixture, tablet, capsule, granule, syrup, decoction, tincture, and pill forms. Hunan Hansen Pharmaceutical Co., Ltd. is based in Yiyang, China.

Similar Companies

Industry: Drug Manufacturers - Specialty & Generic (China)

Name	Market Cap (USD) diff.	PE	Country
Zhejiang NHU Company Ltd. SHE: 002001	$15.86B 107.34B CNY 3K%	16.0	China
Haisco Pharmaceutical Group Co., Ltd. SHE: 002653	$9.1B 61.6B CNY 2K%	80.6	China
Dong-E-E-Jiao Co., Ltd. SHE: 000423	$5.22B 35.33B CNY 902%	20.0	China
Shijiazhuang Yiling Pharmaceutical Co., Ltd. SHE: 002603	$4.21B 28.47B CNY 707%	20.8	China
Jilin Aodong Pharmaceutical Group Co., Ltd. SHE: 000623	$3.27B 22.12B CNY 527%	8.1	China
China Resources Double-Crane Pharmaceutical Co.,Ltd. SSE: 600062	$2.74B 18.55B CNY 426%	11.5	China

Industry: Drug Manufacturers - Specialty & Generic (Global)

Name	Market Cap (USD) diff.	PE	Country
Teva Pharmaceutical Industries Ltd. TLV: TEVA	$37.66B 108.92B ILS 7K%	24.2	Israel
Revolution Medicines, Inc. NASDAQ: RVMD	$29.56B 6K%	-	United States
Cipla Ltd. NSE: CIPLA	$11.12B 1.06T INR 2K%	23.4	India
Lupin Ltd. NSE: LUPIN	$11.0B 1.05T INR 2K%	22.7	India
ABIVAX Société Anonyme EPA: ABVX	$8.79B 7.57B EUR 2K%	-	France
Aurobindo Pharma Ltd. NSE: AUROPHARMA	$8.43B 807.02B INR 2K%	23.1	India

chevron_leftBack